Insmed | INSM - Capitalización De Mercado





Capitalización De Mercado Cambio Fecha
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Cytokinetics USD 11.55B 3.36B 2026-06
DBV Technologies USD 1.23B 327M 2026-03
Gilead Sciences USD 206.51B 21.7B 2026-10
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 16.56B 8.37B 2026-10
Novartis USD 288.26B 25.18B 2026-03
Regeneron Pharmaceuticals USD 100.79B 35.42B 2026-10
Sarepta Therapeutics USD 1.9B 388M 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06